You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

EP4 antagonist

Showing 1 - 25 of 7,173
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Rheumatoid Arthritis, DMARD-naive and Early Disease Patients Trial in Prague (CR6086, Methotrexate, Placebo)

Completed
  • Rheumatoid Arthritis, DMARD-naive and Early Disease Patients
  • Prague, Czechia
    Institute of Rheumatology
Oct 4, 2021

Refractory Metastatic Colorectal Cancer, Solid Tumor, Metastatic Microsatellite-stable Colorectal Cancer Trial in Milano

Recruiting
  • Refractory Metastatic Colorectal Cancer
  • +3 more
  • Milano, MI, Italy
    Istituto Nazionale dei Tumori
Jan 24, 2022

Colorectal Carcinoma (CRC), Endometrial Carcinoma (EC) Trial in Oklahoma City (TPST-1495)

Not yet recruiting
  • Colorectal Carcinoma (CRC)
  • Endometrial Carcinoma (EC)
  • Oklahoma City, Oklahoma
    Stephenson's Cancer Center
Nov 8, 2023

SMART Protocol vs Antagonist Protocol in IVF

Active, not recruiting
  • Diminished Ovarian Reserve
    • Montreal, Quebec, Canada
      Clinique Ovo
    Dec 22, 2022

    POSEIDON Group 3 and Group 4 as Regards IVF

    Enrolling by invitation
    • Infertility, Female
    • IVF
    • Antagonist protocol for induction of ovulation
    • Cairo, Egypt
      Ain Shams University
    Mar 19, 2023

    Prostatic Hyperplasia, Prostate Cancer Trial in Turku (Prostate hyperplasia medication, LhRH-antagonist)

    Recruiting
    • Prostatic Hyperplasia
    • Prostate Cancer
    • Turku, Finland
    • +1 more
    Aug 17, 2023

    Partial Seizures Trial in Japan (Levetiracetam)

    Active, not recruiting
    • Partial Seizures
    • Fukuoka, Japan
    • +20 more
    Mar 10, 2022

    Prostate Cancer, NSCLC, Breast Cancer Trial (RQ-00000007, Gemcitabine)

    Withdrawn
    • Prostate Cancer
    • +2 more
    • (no location specified)
    Oct 31, 2019

    Adverse Effect Trial (normal saline, Ondansetron 4 mg, Ondansetron 8 mg)

    Not yet recruiting
    • Adverse Effect
    • normal saline
    • +2 more
    • (no location specified)
    Jul 25, 2022

    Metastatic Pancreatic Adenocarcinoma, Recurrent Pancreatic Adenocarcinoma, Stage IV Pancreatic Cancer AJCC v6 and v7 Trial in

    Active, not recruiting
    • Metastatic Pancreatic Adenocarcinoma
    • +2 more
    • CXCR4 Antagonist BL-8040
    • +2 more
    • Houston, Texas
      M D Anderson Cancer Center
    Feb 9, 2022

    Female Infertility Trial in Alexandria (Estradiol Valerate 4mg)

    Completed
    • Female Infertility
    • Estradiol Valerate 4mg
    • Alexandria, Egypt
      IVF center
    Jan 20, 2022

    Migraine Trial in Los Angeles, Newport Beach, Waterbury (Galcanezumab, Erenumab)

    Completed
    Has Results
    • Migraine
    • Los Angeles, California
    • +2 more
    Feb 23, 2022

    Cancer Trial in L'Hospitalet de Llobregat (MBF-362)

    Recruiting
    • Cancer
    • L'Hospitalet de Llobregat, Barcelona, Spain
      Instituto Catalan de Oncología
    Jul 7, 2023

    Advanced Solid Tumor, Breast Cancer, Non Small Cell Lung Cancer Trial (MB1707)

    Not yet recruiting
    • Advanced Solid Tumor
    • +4 more
    • (no location specified)
    Jul 18, 2022

    Female Infertility Trial in Alexandria (Growth Hormone)

    Completed
    • Female Infertility
    • Growth Hormone
    • Alexandria, Egypt
      faculty of medicine, Alexandria University
    Aug 8, 2022

    Chronic Kidney Diseases Trial in Worldwide (Zibotentan, Dapagliflozin, Placebo)

    Enrolling by invitation
    • Chronic Kidney Diseases
    • Aurora, Colorado
    • +5 more
    Oct 18, 2022

    Neurologic Physiology After Removal of Therapy (NeuPaRT)

    Not yet recruiting
    • Determination of Death
    • electroencephalography (EEG)
    • Calgary, Alberta, Canada
    • +4 more
    Aug 17, 2022

    Cardiac Arrhythmia Trial in Prague, Copenhagen (EP Procedure)

    Completed
    • Cardiac Arrhythmia
    • EP Procedure
    • Prague, Czechia
    • +1 more
    Jan 18, 2022

    Meningioma Trial in Basel (177Lu-DOTA-JR11 (Phase 0); Cycle 1 and Cycle 2 (cross-over), 177Lu-DOTATOC (Phase 0); Cycle 1 and

    Recruiting
    • Meningioma
    • 177Lu-DOTA-JR11 (Phase 0); Cycle 1 and Cycle 2 (cross-over)
    • +2 more
    • Basel, Basel-Stadt, Switzerland
      University Hospital Basel, Department of Neurosurgery
    Aug 2, 2021

    Iron Deficiency Trial in Zürich (SIC, SIC + AA combined, FeSO4)

    Completed
    • Iron Deficiency
    • SIC
    • +5 more
    • Zürich, ZH, Switzerland
      ETH Zürich, Laboratory of Human Nutrition
    Mar 24, 2021

    Benign Prostatic Hyperplasia (BPH) Trial in Glenview (Adalimumab)

    Not yet recruiting
    • Benign Prostatic Hyperplasia (BPH)
    • Glenview, Illinois
      NorthShore University HealthSystem
    Sep 25, 2023

    Adamantinomatous Craniopharyngioma, Recurrent Adamantinomatous Craniopharyngioma Trial in Worldwide (Tocilizumab)

    Recruiting
    • Adamantinomatous Craniopharyngioma
    • Recurrent Adamantinomatous Craniopharyngioma
    • Aurora, Colorado
    • +17 more
    Jan 8, 2023

    Drug-resistant Epilepsy, Focal-Onset Seizures Trial in Worldwide (Padsevonil, Placebo)

    Completed
    Has Results
    • Drug-resistant Epilepsy
    • Focal-Onset Seizures
    • Chandler, Arizona
    • +147 more
    Mar 16, 2021

    Assessing Causality of CREBBP and EP300 Variants.

    Recruiting
    • Rubinstein-Taybi Syndrome
    • skin biopsy for the primary fibroblast culture and a 15 ml blood sample (3 unnamed samples of 5ml) in each of the 4 SRT patients included.
    • +4 more
    • Talence, France
      Centre Hospitalier Universitaire de Bordeaux
    Oct 7, 2021

    Breast Carcinoma, Estrogen Receptor Positive Trial in Palo Alto (drug, procedure, device)

    Suspended
    • Breast Carcinoma
    • Estrogen Receptor Positive
    • Gallium Ga 68-labeled GRPR Antagonist BAY86-7548
    • +3 more
    • Palo Alto, California
      Stanford Cancer Institute Palo Alto
    Dec 8, 2021